Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 0.4302
-4.19 %
$ 434 M
Market Cap
-0.38
P/E
1. INTRINSIC VALUE
FINANCIALS
Balance Sheet
Tilray Brands, Inc.
| Current Assets | 678 M |
| Cash & Short-Term Investments | 261 M |
| Receivables | 102 M |
| Other Current Assets | 315 M |
| Non-Current Assets | 3.66 B |
| Long-Term Investments | 7.86 M |
| PP&E | 574 M |
| Other Non-Current Assets | 3.08 B |
| Current Liabilities | 299 M |
| Accounts Payable | 105 M |
| Short-Term Debt | 39 M |
| Other Current Liabilities | 155 M |
| Non-Current Liabilities | 593 M |
| Long-Term Debt | 348 M |
| Other Non-Current Liabilities | 245 M |
EFFICIENCY
Earnings Waterfall
Tilray Brands, Inc.
| Revenue | 789 M |
| Cost Of Revenue | 566 M |
| Gross Profit | 223 M |
| Operating Expenses | 398 M |
| Operating Income | -175 M |
| Other Expenses | 47.7 M |
| Net Income | -222 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Tilray Brands, Inc.
| Net Income | -222 M |
| Depreciation & Amortization | 127 M |
| Capital Expenditures | -29.2 M |
| Stock-Based Compensation | 0 |
| Change in Working Capital | -8.87 M |
| Others | 103 M |
| Free Cash Flow | -60.2 M |
Wall Street Analysts Price Targets
Tilray Brands, Inc.
Wall Street analysts predict an average 1-year price target for TLRY of $2.59 , with forecasts ranging from
a
low of
$2 to a high of $4.15 .
TLRY Lowest Price Target
Wall Street Target
2 USD
364.90%
TLRY Average Price Target
Wall Street Target
2.59 USD
502.71%
TLRY Highest Price Target
Wall Street Target
4.15 USD
864.67%
4. DIVIDEND
ANALYSIS
TLRY does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Tilray Brands, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
35.4 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Blue Point Brewing Co. Announces the Return of Delayed Pilsner
PATCHOGUE, N.Y., May 06, 2025 (GLOBE NEWSWIRE) -- Blue Point Brewing Co., a Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY) craft beer brand, announces the highly anticipated re-release of Delayed Pilsner, a beer crafted to soothe the soul of every New Yorker facing the inevitable delays of city life.
globenewswire.com
- 2 weeks ago
High Potential: Canadian Cannabis Stocks Making Waves in May 2025
The U.S. cannabis industry continues to gain momentum in 2025. Experts estimate the market will surpass $45 billion this year. Many states are pushing new legislation to legalize adult-use cannabis. Recreational marijuana is now legal in almost half of the United States. This trend boosts investor confidence across the North American cannabis sector. Canadian companies with exposure to the U.S. market stand to benefit. Recent discussions at the federal level signal possible regulatory reform. These changes may include reclassifying cannabis to a lower risk category. If approved, this could open doors for wider medical research and commercial growth. Therefore, Canadian cannabis stocks are worth watching this week. They offer exposure to both Canadian and potential U.S. demand. Investors are watching for the next catalyst that could move these stocks sharply.
marijuanastocks.com
- 2 weeks ago
Why Tilray Stock Plummeted by 26% in April
The marijuana sector, beset by a host of tough challenges, has been out of favor with investors for years. That looks unlikely to change as long as the drug remains illegal at the federal level, and even that might not save some of the market's players.
fool.com
- 2 weeks ago
10 Barrel Brewing Launches Non-Alcoholic Apocalypse IPA, a Bold Craft Brew for Your Next Adventure
BEND, Ore., April 30, 2025 (GLOBE NEWSWIRE) -- 10 Barrel Brewing, a Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY) craft beer brand, is excited to announce the launch of NA Apocalypse IPA, a non-alcoholic version of their beloved Apocalypse IPA . This new offering delivers the same bold, hop-driven flavor that fans have come to love, now without the alcohol.
globenewswire.com
- 2 weeks ago
Widmer Brothers Brewing Celebrates 40th Anniversary
Portland Brewery Marks Four Decades of Widmer Beer with ‘40 Years of Cheers' and Re-release of Four Iconic Brews Portland Brewery Marks Four Decades of Widmer Beer with ‘40 Years of Cheers' and Re-release of Four Iconic Brews
globenewswire.com
- 3 weeks ago
Tilray Brands Could Bounce Big
Tilray Brands missed Q3 expectations but improved its balance sheet, with net debt at $14 million. Despite revenue and EBITDA misses, Tilray's valuation is attractive, trading at 6.85X projected FY27 adjusted EBITDA, suggesting potential gains of up to 77%. Risks include NASDAQ delisting and integration challenges from numerous acquisitions, but maintaining the NASDAQ listing is crucial.
seekingalpha.com
- 3 weeks ago
Terrapin Beer Co. Celebrates 23 Years of Craft Beer and Environmental Stewardship with Terraprint Initiative and Orvis Partnership
ATHENS, Ga., April 24, 2025 (GLOBE NEWSWIRE) -- Terrapin Beer, a leading craft brewery known for its innovative and high-quality beers and a Tilray Brands, Inc., craft beer brand (NASDAQ: TLRY and TSX: TLRY), is thrilled to partner with Orvis, the renowned outdoor retailer and fly-fishing expert.
globenewswire.com
- 3 weeks ago
Breckenridge Distillery Announces Re-Release of Award-Winning Cognac Cask Finish Whiskey
Following a limited release in 2022 for the Collectors Art Series, Breckenridge Cognac Cask Finish Whiskey is now a permanent addition to the cask finish line Following a limited release in 2022 for the Collectors Art Series, Breckenridge Cognac Cask Finish Whiskey is now a permanent addition to the cask finish line
globenewswire.com
- 3 weeks ago
April 2025's Canadian Cannabis Stock Picks: Growth and Opportunity
As the U.S. cannabis industry continues to grow, Canadian cannabis stocks are gaining momentum with investors. The U.S. market is expected to reach over $44 billion in 2025. By 2030, analysts believe it could climb to more than $75 billion. Adult-use cannabis is now legal in nearly half of the U.S. states. Many others permit medical use, creating widespread demand. At the same time, lawmakers are again discussing federal reform bills. These bills aim to provide national guidelines and unlock interstate trade. Although legalization has faced delays, investor sentiment remains optimistic. Canadian companies are preparing to scale their U.S. operations once laws change.
marijuanastocks.com
- 4 weeks ago
Tilray Beverages Launches Cruisies, a New Line of Ready-To-Drink Cocktails
Keep it Cruisie: Enjoy a Taste of the No Frills, Good Life on The East End this Summer Keep it Cruisie: Enjoy a Taste of the No Frills, Good Life on The East End this Summer
globenewswire.com
- 1 month ago
Tilray Medical Introduces Cannabis Edibles in Australia
SYDNEY, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, has announced the availability of its medical cannabis edibles, Good Supply Pastilles, to patients in Australia. This launch marks Tilray Medical's first medical cannabis edible offering in the country, providing patients with a sugar-free and vegan-friendly treatment option.
globenewswire.com
- 1 month ago
Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders
NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced a special meeting of stockholders (the “Special Meeting”) on June 10, 2025. The Special Meeting will be held via live audio webcast, which can be accessed on the investor page on Tilray.com.
globenewswire.com
- 1 month ago
8. Profile
Summary
Tilray Brands, Inc. TLRY
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 434 M
Dividend Yield
0.00%
Description
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Contact
265 Talbot Street West, Leamington, ON, N8H 5L4
https://www.tilray.com
IPO
Date
July 19, 2018
Employees
2650
Officers
Mr. Lloyd Brathwaite
Chief Information Officer
Mr. Blair MacNeil CMA, CPA
President of Tilray Canada
Ms. Berrin Noorata
Chief Corporate Affairs Officer
Mr. Roger Savell
Chief Administrative Officer & Chief Financial Officer of International
Ms. Denise Menikheim Faltischek
Chief Strategy Officer & Head of International
Mr. Ty H. Gilmore
President of U.S. Beer
Ms. Nyree Pinto
Chief Human Resources Officer
Mr. Irwin David Simon
President, Chief Executive Officer & Chairman
Mr. Mitchell S. Gendel J.D.
Global General Counsel & Corporate Secretary
Mr. Carl A. Merton CA, CBV, CPA
Chief Financial Officer & Principal Accounting Officer